# Apatinib Treatment for Advanced Esophagus Cancer

> **NCT03170310** · PHASE2 · UNKNOWN · sponsor: **Henan Cancer Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Advanced Esophagus Cancer

## Interventions

- **DRUG:** Apatinib

## Key facts

- **NCT ID:** NCT03170310
- **Lead sponsor:** Henan Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-21
- **Primary completion:** 2019-02-21
- **Final completion:** 2019-09-21
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2017-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03170310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03170310, "Apatinib Treatment for Advanced Esophagus Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03170310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*